Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 162

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery

Open access
Guedeney, Nicolas, Cornu, Marie, Schwalen, Florian, Kieffer, Charline, Voisin-Chiret, Anne Sophie · 2023 · Drug Discovery Today

Abstract

Target protein degradation (TPD) is a new avenue that is revolutionary for therapeutics because it redefines the principles of classical drug discovery, guided by event-based target activity rather than by occupancy-driven activity. Since the discovery of the first proteolysis-targeting chimera (PROTAC) in 2001, TPD represents a rapidly growing technology, with applications in both drug discovery and chemical biology. Over the past decade, many questions have been raised, some of which have been addressed, although there is still a long way to go. In this review, we discuss the challenges that the PROTAC strategy has recently addressed in drug design and discovery by highlighting recent results from the literature, and provide guidelines for medicinal chemists interested in the design of new PROTACs as successful therapeutic modalities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2022.103395

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 162

Metadata

Authors
Guedeney, N., Cornu, M., Schwalen, F., Kieffer, C., & Voisin-Chiret, A. S.
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2023-01
Volume
28
Issue
1
Pages
103395
ISSN
1359-6446 (ISSN-L)
OpenAlex
W4304080843
Cited by
162
References
32
FWCI
7.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery. https://app.cochat.ai/papers/10.1016/j.drudis.2022.103395
The paper
Guedeney, N., Cornu, M., Schwalen, F., Kieffer, C., & Voisin-Chiret, A. S. (2023). PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2022.103395

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.